These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32550894)
21. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
22. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery. Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976 [TBL] [Abstract][Full Text] [Related]
23. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy. Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949 [TBL] [Abstract][Full Text] [Related]
24. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery. Chu B; Deng H; Niu T; Qu Y; Qian Z Small Methods; 2024 Aug; 8(8):e2301271. PubMed ID: 38085682 [TBL] [Abstract][Full Text] [Related]
25. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery. Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120 [TBL] [Abstract][Full Text] [Related]
26. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971 [TBL] [Abstract][Full Text] [Related]
27. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release. Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900 [TBL] [Abstract][Full Text] [Related]
28. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy. Wang Z; Wu H; Liu P; Zeng F; Wu S Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754 [TBL] [Abstract][Full Text] [Related]
29. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy. Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873 [TBL] [Abstract][Full Text] [Related]
30. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery. Li Y; Lu H; Liang S; Xu S ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440 [TBL] [Abstract][Full Text] [Related]
31. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers. Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720 [TBL] [Abstract][Full Text] [Related]
32. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity. Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824 [TBL] [Abstract][Full Text] [Related]
33. Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin. Wu Y; Zhou D; Zhang Q; Xie Z; Chen X; Jing X; Huang Y Biomacromolecules; 2016 Aug; 17(8):2650-61. PubMed ID: 27384255 [TBL] [Abstract][Full Text] [Related]
34. Exquisite Vesicular Nanomedicine by Paclitaxel Mediated Co-assembly with Camptothecin Prodrug. Zhou Z; Du C; Zhang Q; Yu G; Zhang F; Chen X Angew Chem Int Ed Engl; 2021 Sep; 60(38):21033-21039. PubMed ID: 34278702 [TBL] [Abstract][Full Text] [Related]
35. Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy. Zong Z; Hua L; Wang Z; Xu H; Ye C; Pan B; Zhao Z; Zhang L; Lu J; Mei LH; Rutong Y Drug Deliv; 2019 Dec; 26(1):34-44. PubMed ID: 30744436 [TBL] [Abstract][Full Text] [Related]
36. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression. Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934 [TBL] [Abstract][Full Text] [Related]
37. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Wang W; Xi M; Duan X; Wang Y; Kong F Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664 [TBL] [Abstract][Full Text] [Related]
38. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. Bala V; Rao S; Boyd BJ; Prestidge CA J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356 [TBL] [Abstract][Full Text] [Related]
39. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767 [TBL] [Abstract][Full Text] [Related]
40. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin. Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]